XSAU
1212
Market cap3.06bUSD
Nov 12, Last price
143.50SAR
Name
Astra Industrial Group Company SJSC
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Astra Industrial Group Company functions as a diversified holding entity, conducting its operations globally through a network of subsidiaries. Its extensive international reach encompasses the Kingdom of Saudi Arabia, various parts of Africa, the United States, Asia, and Europe. The company's broad portfolio of activities includes: Pharmaceuticals: Engaging in the research, production, marketing, and distribution of both branded generic and licensed medicinal products. These address critical therapeutic areas, including central nervous system conditions, cardiovascular health, infectious diseases, respiratory illnesses, and musculoskeletal system disorders. Specialty Chemicals: Manufacturing key ingredients such as masterbatches, dust-free additives, customized thermoplastic compounds, and a variety of liquid and paste colorants, primarily serving the polymer processing, manufacturing, and converting sectors. Agriculture: Producing, importing, and distributing a wide array of agrochemicals, fertilizers, pesticides for public health and veterinary use, seeds, and other essential agricultural supplies. Power and Steel: Producing pre-engineered steel buildings, various steel structures, and fundamental steel products like billets and rebars, predominantly for the construction industry. The company also conducts exploration for ores and minerals as part of its mining operations. Industrial Ventures: Actively involved in the development, operation, management, and investment in industrial plants, alongside undertaking metal-based construction for buildings and structural frameworks. Astra Industrial Group Company was founded in 1988 and is headquartered in Riyadh, Saudi Arabia.
Valuation
Title SAR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||